Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pragmatic, Individually Randomised, Double-blind, Placebo-controlled Trial of Triazavirin (TZV) for the Treatment of Mild-moderate SARS-CoV-2 Infection A Phase II and III Clinical Trial

NCT04581915 is registered in ClinicalTrials.gov with Wits Health Consortium (Pty) Ltd as lead sponsor.

NCT NCT04581915
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04581915 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pragmatic, Individually Randomised, Double-blind, Placebo-controlled Trial of Triazavirin (TZV) for the Treatment of Mild-moderate SARS-CoV-2 Infection A Phase II and III Clinical Trial
Lead sponsor
Wits Health Consortium (Pty) Ltd
Phase
Phase 2/3
Overall status
Terminated
Start date
September 8, 2020
Completion date
April 20, 2021
Enrollment
74 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19